Ignyte Acquisition priced its IPO of 50 million units at $10 each to raise $50 million.
Units begin trading today on the Nasdaq under IGNYU.
The new SPAC is focused on the life sciences, biotechnology and healthcare sectors.
Ignyte is led by Chairman and Co-CEO David Rosenberg, the co-CEO and co-president of Ladenburg Thalmann. Read more.
